Literature DB >> 24700441

Evaluation of participant recruitment methods to a rare disease online registry.

Kimberly J Johnson1, Nancy L Mueller, Katherine Williams, David H Gutmann.   

Abstract

Internet communication advances provide new opportunities to assemble individuals with rare diseases to online patient registries from wide geographic areas for research. However, there is little published information on the efficacy of different recruitment methods. Here we describe recruitment patterns and the characteristics of individuals with the self-identified autosomal dominant genetic disorder neurofibromatosis type 1 (NF1) who participated in an online patient registry during the 1-year period from 1/1/2012 to 12/31/2012. We employed four main mechanisms to alert potential participants to the registry: (1) Facebook and Google advertising, (2) government and academic websites, (3) patient advocacy groups, and (4) healthcare providers. Participants reported how they first heard about the registry through an online questionnaire. During the 1-year period, 880 individuals participated in the registry from all 50 U.S. States, the District of Columbia, Puerto Rico, and 39 countries. Facebook and Google were reported as referral sources by the highest number of participants (n=550, 72% Facebook), followed by healthcare providers (n=74), and government and academic websites (n=71). The mean participant age was 29±18 years and most participants reported White race (73%) and female sex (62%) irrespective of reported referral source. Internet advertising, especially through Facebook, resulted in efficient enrollment of large numbers of individuals with NF1. Our study demonstrates the potential utility of this approach to assemble individuals with a rare disease from across the world for research studies.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Internet; NF1; genetic syndrome; neurofibromatosis type 1; online; rare disease; registry

Mesh:

Year:  2014        PMID: 24700441     DOI: 10.1002/ajmg.a.36530

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  22 in total

Review 1.  What can Duchenne Connect teach us about treating Duchenne muscular dystrophy?

Authors:  Richard T Wang; Stanley F Nelson
Journal:  Curr Opin Neurol       Date:  2015-10       Impact factor: 5.710

2.  Physical Accessibility of Routine Prenatal Care for Women with Mobility Disability.

Authors:  Lisa I Iezzoni; Amy J Wint; Suzanne C Smeltzer; Jeffrey L Ecker
Journal:  J Womens Health (Larchmt)       Date:  2015-10-20       Impact factor: 2.681

3.  Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1.

Authors:  Kimberly J Johnson; Nancy L Zoellner; David H Gutmann
Journal:  Cancer Epidemiol       Date:  2016-03-25       Impact factor: 2.984

4.  Recommendations about Pregnancy from Women with Mobility Disability to Their Peers.

Authors:  Lisa I Iezzoni; Amy J Wint; Suzanne C Smeltzer; Jeffrey L Ecker
Journal:  Womens Health Issues       Date:  2016-10-20

5.  Racial/Ethnic Differences in Pediatric Brain Tumor Diagnoses in Patients with Neurofibromatosis Type 1.

Authors:  Salmafatima S Abadin; Nancy L Zoellner; Melody Schaeffer; Bree Porcelli; David H Gutmann; Kimberly J Johnson
Journal:  J Pediatr       Date:  2015-05-28       Impact factor: 4.406

6.  Effects of disability on pregnancy experiences among women with impaired mobility.

Authors:  Lisa I Iezzoni; Amy J Wint; Suzanne C Smeltzer; Jeffrey L Ecker
Journal:  Acta Obstet Gynecol Scand       Date:  2014-12-25       Impact factor: 3.636

7.  Validating online approaches for rare disease research using latent class mixture modeling.

Authors:  Andrew A Dwyer; Ziwei Zeng; Christopher S Lee
Journal:  Orphanet J Rare Dis       Date:  2021-05-10       Impact factor: 4.123

8.  Involvement of mental health professionals in the treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND): results of a multinational European electronic survey.

Authors:  Robert Waltereit; Guillaume Beaure d'Augères; Jasna Jancic; John Chris Kingswood; Maya Koleva; Ruben Marques; Vicente Villanueva; Stéphane Auvin
Journal:  Orphanet J Rare Dis       Date:  2021-05-12       Impact factor: 4.123

9.  Barriers and facilitators for clinical trial participation of underrepresented and non-underrepresented fibromyalgia patients: A cross-sectional internet survey.

Authors:  Alejandra Cardenas-Rojas; Kevin Pacheco-Barrios; Luis Castelo-Branco; Stefano Giannoni-Luza; Ana Balbuena-Pareja; Maria Alejandra Luna-Cuadros; Luna Vasconcelos Felippe; Elif Uygur-Kucukseymen; Paola Gonzalez-Mego; Muhammed Enes Gunduz; Emad Salman Shaikh; Anna Carolyna Lepesteur Gianlorenco; Felipe Fregni
Journal:  Heliyon       Date:  2021-07-05

10.  Opportunities and pitfalls of social media research in rare genetic diseases: a systematic review.

Authors:  Emily G Miller; Amanda L Woodward; Grace Flinchum; Jennifer L Young; Holly K Tabor; Meghan C Halley
Journal:  Genet Med       Date:  2021-07-19       Impact factor: 8.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.